| Offering Information |
| Expected Date | WITHDRAWN |
| Proposed Exchange/Ticker |
TORON: AKL |
| Security Type |
Common Stock |
| Lead Underwriter |
Lazard Capital Markets |
| Days In Registration |
98 |
| Date Filed |
12-Oct-2007 |
| Form Filed | F-1 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Akela Pharma Inc, located in St Laurent, Quebec, manufactures prescription pharmaceuticals intended for final consumption, including biotech products and antibiotics and provide contract research services. The company was founded in 1998. |
| Revenue |
$13.4M |
| Net Income |
-$34.8M |
| Shares Outstanding (post-offering) |
17.02M |
| Contact |
- |
| Number of Employees |
390 |
|
| Original Filing Information |
| US |
| Shares Filed |
5.25M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
- |
| · As a Percent |
- |
| Overallotment Shares Filed |
787.5K |
| File Amount |
- |
| File Price Range |
$8.00 - $6.00 |
| File Mid Price |
$7.00 |
|
